Virginia G. Kaklamani, MD, DSc, discusses datopotamab deruxtecan and other antibody-drug conjugates available for patients with unresectable or metastatic hormone receptor-positive, HER2-negative ...

Keytruda (pembrolizumab) plus Lenvima (lenvatinib) and chemotherapy improved progression-free survival but did not achieve ...

Merck & Co. and Eisai have to deal with the reality that yet another phase 3 trial of their combination of Keytruda and ...

Both regimens “can be considered standard chemotherapy options” for high-risk, HR-positive early breast cancer, said Sherko Kuemmel, MD, PhD.

Miller took the Government to court twice during her anti-Brexit campaign and became a hate figure for many Brexiteers - ...

Cantor Fitzgerald reaffirmed its Overweight rating on ALX Oncology (NASDAQ:ALXO), following the presentation of positive Phase 2 ASPEN-6 study results. According to InvestingPro data, the company's ...

A new statistical tool that combines multiple clinical and pathologic factors with a patient's 21-gene Oncotype DX Breast ...

Sam Mercer, 51, was in a "wonderful" place in her life and had recently got married when she began to feel unwell, but ...

EXCLUSIVE: A British woman was diagnosed with stage three breast cancer after noticing the sort of change to her body that ...

EXUMA Biotech, Corp., a clinical-stage biotechnology company discovering and developing cell and gene immunotherapies for solid and hematological malignancies, is presenting clinical data from a ...

Metastatic Breast Cancer MBC is an advanced form of breast cancer that can spread from the breast to other parts of the body ...